Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction
| dc.contributor.author | Vrieling, Frank | en_ZA |
| dc.contributor.author | Wilson, Louis | en_ZA |
| dc.contributor.author | Rensen, Patrick C. N. | en_ZA |
| dc.contributor.author | Walzl, Gerhard | en_ZA |
| dc.contributor.author | Ottenhoff, Tom H. M. | en_ZA |
| dc.contributor.author | Joosten, Simone A. | en_ZA |
| dc.date.accessioned | 2021-09-27T07:06:22Z | |
| dc.date.available | 2021-09-27T07:06:22Z | |
| dc.date.issued | 2019 | |
| dc.description | CITATION: Vrieling, F., et al. 2019. Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction. PLoS Pathogens, 15(4): e1007724, doi:10.1371/journal.ppat.1007724. | |
| dc.description | The original publication is available at https://journals.plos.org/plospathogens | |
| dc.description.abstract | ENGLISH ABSTRACT: Type 2 diabetes mellitus (DM) is a major risk factor for developing tuberculosis (TB). TB-DM comorbidity is expected to pose a serious future health problem due to the alarming rise in global DM incidence. At present, the causal underlying mechanisms linking DM and TB remain unclear. DM is associated with elevated levels of oxidized low-density lipoprotein (oxLDL), a pathologically modified lipoprotein which plays a key role during atherosclerosis development through the formation of lipid-loaded foamy macrophages, an event which also occurs during progression of the TB granuloma. We therefore hypothesized that oxLDL could be a common factor connecting DM to TB. To study this, we measured oxLDL levels in plasma samples of healthy controls, TB, DM and TB-DM patients, and subsequently investigated the effect of oxLDL treatment on human macrophage infection with Mycobacterium tuberculosis (Mtb). Plasma oxLDL levels were significantly elevated in DM patients and associated with high triglyceride levels in TB-DM. Strikingly, incubation with oxLDL strongly increased macrophage Mtb load compared to native or acetylated LDL (acLDL). Mechanistically, oxLDL -but not acLDL- treatment induced macrophage lysosomal cholesterol accumulation and increased protein levels of lysosomal and autophagy markers, while reducing Mtb colocalization with lysosomes. Importantly, combined treatment of acLDL and intracellular cholesterol transport inhibitor (U18666A) mimicked the oxLDL-induced lysosomal phenotype and impaired macrophage Mtb control, illustrating that the localization of lipid accumulation is critical. Collectively, these results demonstrate that oxLDL could be an important DM-associated TB-risk factor by causing lysosomal dysfunction and impaired control of Mtb infection in human macrophages. | en_ZA |
| dc.description.uri | https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007724 | |
| dc.description.version | Publisher's version | |
| dc.format.extent | 27 pages | en_ZA |
| dc.identifier.citation | Vrieling, F., et al. 2019. Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction. PLoS Pathogens, 15(4): e1007724, doi:10.1371/journal.ppat.1007724 | |
| dc.identifier.issn | 1553-7374 (online) | |
| dc.identifier.other | doi:10.1371/journal.ppat.1007724 | |
| dc.identifier.uri | http://hdl.handle.net/10019.1/123077 | |
| dc.language.iso | en_ZA | en_ZA |
| dc.publisher | Public Library of Science | en_ZA |
| dc.rights.holder | Authors retain copyright | en_ZA |
| dc.subject | Type 2 diabetes | en_ZA |
| dc.subject | Low density lipoproteins -- Oxidation | en_ZA |
| dc.subject | Mycobacterium tuberculosis | en_ZA |
| dc.subject | Macrophages | en_ZA |
| dc.subject | Lysosomal disorders | en_ZA |
| dc.title | Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction | en_ZA |
| dc.type | Article | en_ZA |